Explore more publications!
Healthcare Wire Texas
Submit Press Release

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 20, 2025

Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium
October 20, 2025

Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium

Indeterminate GlobeNewswire
AMA Launches Center for Digital Health and AI to Put Physicians at the Heart of Health Care Innovation
October 20, 2025

AMA Launches Center for Digital Health and AI to Put Physicians at the Heart of Health Care Innovation

Indeterminate GlobeNewswire
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
October 20, 2025

KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery

Indeterminate GlobeNewswire
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
October 20, 2025

YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES

Indeterminate GlobeNewswire
Solana Company Executive Chairman’s Message: October 20th, 2025
October 20, 2025

Solana Company Executive Chairman’s Message: October 20th, 2025

Indeterminate GlobeNewswire
New Jersey Families Challenged to Tackle Prescription Drug Misuse
October 20, 2025

New Jersey Families Challenged to Tackle Prescription Drug Misuse

Indeterminate GlobeNewswire
American Families Challenged to Tackle Prescription Drug Misuse
October 20, 2025

American Families Challenged to Tackle Prescription Drug Misuse

Indeterminate GlobeNewswire
AIM ImmunoTech to Attend the 2025 Maxim Growth Summit
October 20, 2025

AIM ImmunoTech to Attend the 2025 Maxim Growth Summit

Indeterminate GlobeNewswire
Eleos to Launch Polaris AI Advanced, Purpose-Built Foundational AI Model for Post-Acute Care, built with Google Cloud Technology
October 20, 2025

Eleos to Launch Polaris AI Advanced, Purpose-Built Foundational AI Model for Post-Acute Care, built with Google Cloud Technology

Indeterminate GlobeNewswire
Muscular Dystrophy Association Launches Holiday Retail Campaign in Thousands of Retail Locations Nationwide
October 20, 2025

Muscular Dystrophy Association Launches Holiday Retail Campaign in Thousands of Retail Locations Nationwide

Indeterminate GlobeNewswire
VitalHub Announces Q3 2025 Conference Call Date
October 20, 2025

VitalHub Announces Q3 2025 Conference Call Date

Indeterminate GlobeNewswire
ADARx Pharmaceuticals Announces Clinical Data Presentation at the American Society of Nephrology (ASN) Kidney Week 2025
October 20, 2025

ADARx Pharmaceuticals Announces Clinical Data Presentation at the American Society of Nephrology (ASN) Kidney Week 2025

Indeterminate GlobeNewswire
Avance Clinical Launches Dedicated Center of Excellence to Accelerate Early Phase Biotech Trials
October 20, 2025

Avance Clinical Launches Dedicated Center of Excellence to Accelerate Early Phase Biotech Trials

Indeterminate GlobeNewswire
AAMI and TechNation Collaborate to Survey HTM Field
October 20, 2025

AAMI and TechNation Collaborate to Survey HTM Field

Indeterminate GlobeNewswire
Palisade Bio Announces First Patients Dosed in Phase 1b Study of Oral First-In-Class PDE4 Inhibitor Prodrug, PALI-2108, for the Treatment of Fibrostenotic Crohn’s Disease (FSCD)
October 20, 2025

Palisade Bio Announces First Patients Dosed in Phase 1b Study of Oral First-In-Class PDE4 Inhibitor Prodrug, PALI-2108, for the Treatment of Fibrostenotic Crohn’s Disease (FSCD)

Indeterminate GlobeNewswire
OneMedNet Welcomes Our Latest Subscriber mlHealth360
October 20, 2025

OneMedNet Welcomes Our Latest Subscriber mlHealth360

Indeterminate GlobeNewswire
SARMs RAD 140 (Testolone) and IBUTAMOREN MK-677 SARMS Stack: Crazy Bulk Lunch Rad 140 Effective Sarms for Bulking and Muscle Growth in 2025
October 20, 2025

SARMs RAD 140 (Testolone) and IBUTAMOREN MK-677 SARMS Stack: Crazy Bulk Lunch Rad 140 Effective Sarms for Bulking and Muscle Growth in 2025

Indeterminate GlobeNewswire
Cogent Biosciences Announces FDA Breakthrough Therapy Designation for Bezuclastinib
October 20, 2025

Cogent Biosciences Announces FDA Breakthrough Therapy Designation for Bezuclastinib

Indeterminate GlobeNewswire
EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU
October 20, 2025

EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU

Indeterminate GlobeNewswire
Clene to Present at the Emerging Growth Conference
October 20, 2025

Clene to Present at the Emerging Growth Conference

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions